New HHS Drug Importation Proposals Aim to Address High Costs
The Department of Health and Human Services is taking the first steps in allowing drugs to be imported into the United States from Canada.
Related Articles
Peripheral Arterial and Aortic Diseases: Primary Care
An up-to-date overview of the ESC’s 2024 guidance on peripheral arterial and aortic diseases, including comparison with NICE, ESVS, and UK screening guidance
Surviving and Thriving in Medical School: Time Management Tips for Success
Time management is one of the greatest challenges medical students face. Experts offer tips about how to navigate this issue.
Scribe
Welcome to Scribe, your new assistant for clinical note-taking! This HIPAA compliant AI-powered tool listens to your patient visits and creates an EHR-ready summary. Say…
Why ‘Resilience’ Can Be a Loaded Term for Healthcare Workers
“Resilience” has been touted as a remedy for burnout, but many find the term unrealistic within a strained system. Here’s how they make their own…
Ongoing Management of Pain With Opioid Analgesics
Do you know how to appropriately modify opioid analgesic therapy in patients with ongoing acute or chronic pain? Listen to our expert, Dr Timothy Atkinson,…
Point-of-Care Medical Reference App For Doctors | Medscape
Check drug interactions, access 450+ medical calculators, and ID pills at the point-of-care with Medscape’s official app. No hidden costs or subscription fees.
Red Wine May Not Be a Health Tonic, But Is It a Cancer Risk?
While the body of evidence to date shows that alcohol can cause cancer, the data on red wine are less clear-cut.
High Radon Levels Linked to Gestational Diabetes
Women who live in counties with high radon exposure levels had significantly higher odds of developing gestational diabetes.
New Proposed Health Cybersecurity Rule: What Physicians Should Know
A proposed federal rule would require hospitals and physicians’ groups to beef up health cybersecurity measures to protect patient privacy and prevent ransomware attacks. Some…
Change Makers: Richard Francis on the Pillars of Innovation and Growth
One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications…